Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes

NCT01343667 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT01343667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
January 31, 2014
Enrollment
1,397 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, brain diseases, cardiovascular diseases, carotid artery diseases, carotid stenosis, central nervous system diseases, cerebrovascular disorders, constriction, pathologic, nervous system diseases, pathological conditions, anatomical, vascular diseases